Novartis AG ADR (NVS)
Official siteHEALTHCARE • DRUG MANUFACTURERS - GENERAL • NYSE
Market Cap: $303.12B
Last updated: Nov 17, 2026 at 4:33 PM ET
Novartis AG ADR (NVS) Stock Chart
Novartis AG ADR (NVS) has a latest price of $159.16 on Nov 17, 2026, 4.1% below its 52-week high of $165.96. Its price rose 25.0% over the past 12 months. The month-end price rose 126.4% over the 10 years through Oct 2026, a compound annual rate of 8.5%.
Price Chart
From Oct 2016 to Oct 2026, its highest month-end close was $168.62 in Feb 2026 and its lowest $68.76 in Nov 2016, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart NVS with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for NVS.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 0.7%, and over 6 months it rose 5.8%. The month-end price rose 71.8% over the 3 years through Oct 2026, a compound annual rate of 19.8%.
| Period | Change |
|---|---|
| 1 month | +6.0% |
| 3 months | -0.7% |
| 6 months | +5.8% |
| 12 months | +25.0% |
| 12 months, with dividends | +28.7% |
| Period | Change | Per year |
|---|---|---|
| 3 years | +71.8% | +19.8% |
| 5 years | +94.3% | +14.2% |
| 10 years | +126.4% | +8.5% |
Price by Year
Its best calendar year was 2025, when the price rose 41.7%, and its weakest was 2021, when it fell 7.4%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $160.79 | +16.6% |
| 2025 | $137.87 | +41.7% |
| 2024 | $97.31 | -3.6% |
| 2023 | $100.97 | +11.3% |
| 2022 | $90.72 | +3.7% |
| 2021 | $87.47 | -7.4% |
| 2020 | $94.43 | -0.3% |
| 2019 | $94.69 | +10.3% |
| 2018 | $85.81 | +2.2% |
| 2017 | $83.96 | +15.3% |
Trading Range
The price is 6.4% above its 50-day average of $149.57 and 4.7% above its 200-day average of $152.06.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $159.16 | |
| 52-week high | $165.96 | -4.1% |
| 52-week low | $119.60 | +33.1% |
| 50-day average | $149.57 | +6.4% |
| 200-day average | $152.06 | +4.7% |
Price Risk
Over 3 years, its largest fall from a peak was 20.0%.
| Measure | Value |
|---|---|
| 1-year beta | 0.35 |
| Largest fall, 1 year | -16.2% |
| Largest fall, 3 years | -20.0% |
Valuation
Novartis AG ADR traded at 15.4x earnings at the end of 2025, against a 5-year median of 14.6x and a 10-year median of 15.3x.
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About NVS
What is NVS's 1-year price change?
Novartis AG ADR's price rose 25.0% over the past 12 months. With dividends included, the 12-month total return was 28.7%.
What is NVS's 5-year price change?
Novartis AG ADR's month-end price rose 94.3% over the 5 years through Oct 2026, a compound annual rate of 14.2%. These figures leave out dividends.
What is NVS's 52-week high and low?
Novartis AG ADR's 52-week high is $165.96 and its 52-week low is $119.60. Its latest price of $159.16 on Nov 17, 2026 is 4.1% below the high.
What is NVS's beta?
Novartis AG ADR's 1-year beta against the S&P 500 is 0.35, so its price has moved less than the market over the past year. Its largest fall from a peak over the past year was 16.2%.
Is the NVS chart free?
Yes. Advanced Charting for NVS is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
NVS pages: Overview, Dividends, Charting, Earnings, Forecast, Financials, Statistics, Valuation, Competitors, Government Contracts